- Do you, or did you, own shares of Vanda Pharmaceuticals Inc. (NASDAQ GM: VNDA )?
- Did you purchase your shares before December 18, 2012, or between December 18, 2012 and June 18, 2013?
- Did you lose money in your investment in Vanda Pharmaceuticals Inc.?
- Do you want to discuss your rights?
If you wish to serve as lead plaintiff, you must move the Court no later than August 26, 2013. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. In order to be appointed lead plaintiff, the Court must determine that the class member’s claim is typical of the claims of other class members, and that the class member will adequately represent the class. Your ability to share in any recovery is not, however, affected by the decision whether or not to serve as a lead plaintiff. Any member of the proposed class may move the court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.While Rigrodsky & Long, P.A. did not file the Complaint in this matter, the firm, with offices in Wilmington, Delaware and Garden City, New York, regularly litigates securities class, derivative and direct actions, shareholder rights litigation and corporate governance litigation, including claims for breach of fiduciary duty and proxy violations in the Delaware Court of Chancery and in state and federal courts throughout the United States. Attorney advertising. Prior results do not guarantee a similar outcome.